Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr954 Inhibitors

Olfr954, part of the olfactory receptor family 1 subfamily K, plays an essential role in the olfactory system of Mus musculus as a G-protein-coupled receptor (GPCR). This type of receptor is crucial in detecting and transducing odorant molecules, which leads to the perception of smell. Olfr954, like other olfactory receptors, possesses a 7-transmembrane domain structure, a characteristic feature of GPCRs. This structure facilitates its binding to odorant molecules, triggering a cascade of intracellular events culminating in a neuronal response. The ability of Olfr954 to selectively bind to specific odorants and initiate a signaling cascade underscores its critical role in the olfactory system's capacity to distinguish a wide array of scents. The inhibition of Olfr954's function can be achieved through either direct or indirect methods. Direct inhibition would involve targeting the receptor's ligand-binding domain to prevent its interaction with odorant molecules, thereby halting the activation of the associated G-protein and subsequent signal transduction. This approach necessitates a high degree of specificity to avoid unintended effects on other GPCRs. Indirect inhibition, on the other hand, encompasses broader strategies such as altering the receptor's membrane dynamics or conformation, which can affect its ability to bind ligands or activate G-proteins. Additionally, targeting downstream signaling pathways or regulatory mechanisms of the receptor can modulate its activity. Influencing the pathways that regulate receptor desensitization, internalization, or recycling, for instance, can significantly impact the receptor's signaling efficacy. The chemicals listed in the table exemplify potential indirect inhibitors of Olfr954, each acting through distinct mechanisms, such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, or alteration of G-protein coupling. Understanding the mechanisms of Olfr954's function and inhibition is essential for unraveling the complex dynamics of olfactory transduction. Exploring both direct and indirect inhibitory strategies offers insights into the modulation of GPCR activity, especially in the context of olfactory receptors. This knowledge not only advances our understanding of olfactory perception but also contributes to the broader field of GPCR research, which has significant implications in sensory biology and pharmacology. The study of inhibitors of Olfr954 and similar receptors aids in developing a comprehensive understanding of the molecular dynamics governing olfactory signaling and the potential for targeted modulation of these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fexofenadine

83799-24-0sc-218475
100 mg
$298.00
1
(0)

Fexofenadine, a selective H1 antihistamine, indirectly modulates GPCR signaling. By inhibiting histamine action, it reduces the modulation of GPCR activity, potentially decreasing Olfr954 signaling in olfactory pathways.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Carvedilol, a non-selective beta and alpha-1 adrenergic blocker, affects GPCR signaling indirectly. By blocking these receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr954 function.

Esmolol

81147-92-4sc-279019B
sc-279019A
sc-279019
50 mg
100 mg
500 mg
$100.00
$150.00
$650.00
1
(1)

Esmolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr954 function.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

(S)-Omeprazole Sodium Salt, a proton pump inhibitor, can indirectly modulate GPCR activity. By influencing gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr954 signaling.

(S)-Timolol Maleate

26921-17-5sc-203297
sc-203297A
100 mg
250 mg
$61.00
$126.00
(1)

(S)-Timolol Maleate, a non-selective beta-adrenergic receptor blocker, modulates GPCR signaling pathways indirectly. Its action on beta receptors can affect G-protein coupling in related GPCRs, potentially impacting Olfr954.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Nifedipine, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr954.